Omalizumab: A potential new therapeutic approach for aspirin-exacerbated respiratory disease

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 5, 2010, Pages 448-449

  Bobolea, I ^a   Barranco, P ^a   Fiandor, A ^a   Cabanas R ^a   Quirce, S ^a,b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; IBUPROFEN; METHACHOLINE; MONTELUKAST; OMALIZUMAB; PARACETAMOL; TRAMADOL;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CASE REPORT; ENDOSCOPIC SINUS SURGERY; FEMALE; FORCED EXPIRATORY VOLUME; HAY FEVER; HEADACHE; HUMAN; HYPOSMIA; INHALATION TEST; MULTIPLE CYCLE TREATMENT; NOSE POLYP; POLLEN ALLERGY; PROVOCATION TEST;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, PLANT; ASTHMA, ASPIRIN-INDUCED; BRONCHIAL SPASM; COMMON COLD; FEMALE; HUMANS; IBUPROFEN; NASAL OBSTRUCTION; POACEAE; POLLEN; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, SEASONAL;

EID: 78649352533     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Berges-Gimeno M, Simon RA, Stevenson DD. Treatment with aspirin desensitization in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111:180-6.
2. Incorvaia C, Mauro M, Riario-Sforza GG, Frati F, Tarantini F, Caserini M. Current and future applications of the anti-IgE antibody omalizumab. Biologics. 2008;2:67-73.
3. Güzelbey O, Magerl M, Zuberbier T, Maurer M, Metz M. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563
4. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol.2009;44:516.
5. Grundmann SA, Hemfort PB, Luger TA, Brehler R. Anti-IgE (omalizumab): A new therapeutic approach for chronic rhinosinusitis. J Allergy Clin Immunol. 2008;121:257-8
6. M Guglielmo, C Gulotta, F Mancini, M Sacchi, F Tarantini. Recalcitrant Nasal Polyposis: Achievement of Total Remission Following Treatment with Omalizumab. J Investig Allergol Clin Immunol. 2009; 19(2): 158-66.